Journal of Emergencies, Trauma, and Shock
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
Users online:2161   Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size   


 
ORIGINAL ARTICLE Table of Contents   
Year : 2010  |  Volume : 3  |  Issue : 3  |  Page : 213-219
Developing a clinically relevant classification to predict mortality in severe leptospirosis


1 Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka
2 University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka
3 University College London, London, United Kingdom

Click here for correspondence address and email

Date of Submission14-Oct-2009
Date of Acceptance24-Apr-2010
Date of Web Publication19-Jul-2010
 

   Abstract 

Background : Severe leptospirosis requires critical care and has a high mortality. We reviewed the literature to identify factors predicting mortality, and such predictors were classified according to the predisposition, infection, response, organ dysfunction (PIRO) concept, which is a risk stratification model used in severe sepsis. Material and Methods : PUBMED was searched for all articles (English), with the key word "leptospirosis" in any field, within the last 20 years. Data were collected from 45 relevant papers and grouped into each component of the PIRO model. Results : The following correlated with increased mortality: predisposition - increasing age and chronic alcoholism; infection - leptospiraemic burden; response - hemodynamic disturbances, leukocytosis; organ dysfunction - multiple organ dysfunction syndrome, pulmonary involvement and acute renal failure. Conclusions : Further research is needed to identify the role of infecting serovars, clinical signs, inflammatory markers, cytokines and evidence of hepatic dysfunction as prognostic indicators. It is hoped that this paper will be an initiative to create a staging system for severity of leptospirosis based on the PIRO model with an added component for treatment-related predictors.

Keywords: Leptospirosis, mortality, severity

How to cite this article:
Rajapakse S, Rodrigo C, Haniffa R. Developing a clinically relevant classification to predict mortality in severe leptospirosis. J Emerg Trauma Shock 2010;3:213-9

How to cite this URL:
Rajapakse S, Rodrigo C, Haniffa R. Developing a clinically relevant classification to predict mortality in severe leptospirosis. J Emerg Trauma Shock [serial online] 2010 [cited 2019 Dec 6];3:213-9. Available from: http://www.onlinejets.org/text.asp?2010/3/3/213/66519



   Background Top


Leptospirosis is a zoonotic spirochaetal illness with considerable morbidity and mortality in areas of high prevalence. The causative organism is classified in the genus Leptospira. Initially, this genus was thought to have only two species. Currently, nine pathogenic species of Leptospira are identified, with another five being classified as "intermediate," bringing the total number of possible pathogenic species to 14. [1] Rodents, marsupials or any mammal have the potential to be the animal reservoir. The organisms are excreted to the environment via the urine of the host. Transmission to humans can be direct (inoculation via tissues, body fluids and urine of infected animals) or indirect (entry via mucosal surfaces or breached skin from sources contaminated with the causative agent). [2]

An accurate assessment of the disease burden of leptospirosis is not easy due to diagnostic difficulties and under-reporting. The estimated incidence differs as to whether an endemic or a non-endemic area is considered (it is endemic in areas with high rainfall, close human contact with livestock, poor sanitation with workplace exposure to the organism). [3] Such localities, which include pockets in Central America, the Indian subcontinent, Oceania and the Caribbean, have an estimated annual incidence of around 25 clinical infections per 100,000 of population (in contrast to 1 per 100,000 per year in non-endemic areas). [3]

Many infections are asymptomatic or pass off as a mild febrile episode. However, a small proportion develops a severe form of the disease with multiple organ dysfunction. The case fatality ratio in severe disease can exceed 40%. [4] Weil's disease, a severe form of leptospirosis, is characterized by jaundice, hemorrhage and renal failure. In addition, the central nervous system and the cardiovascular system are also affected. [4]

The objectives of this review are two-fold. Firstly, it summarizes the mortality predictors for leptospirosis published by different authors. While some indicators are repeatedly cited as predictors of mortality, the significance of others is questionable. Secondly, an attempt is made to classify such predictors into a clinically relevant classification (based on the predisposition, infection, response, organ dysfunction [PIRO] model).


   Predictors of Mortality ;The Importance of Classification and the PIRO Concept Top


It is our opinion that a simple detailed description of mortality indicators will not be of much use to a clinician in his practice. The clinician will be more interested in a systematic manner of application of such knowledge to predict mortality and identify the "at risk" patients early. The ideal method to integrate such information to an applicable clinical tool is to develop a valid classification and a scoring system.

The PIRO model is a risk stratification system for severe sepsis. PIRO stands for predisposition (P), infection (I), response (R) and organ dysfunction (O) [5] (Similar to the TNM [tumor, nodes, metastases] classification for staging of malignancy). Severe leptospirosis results in sepsis with multiple organ dysfunction syndrome (MODS); however, the pathogenesis and clinical manifestations of leptospirosis are distinct from other bacterial infections resulting in severe sepsis and other viral infections such as dengue that result in widespread systemic manifestations; leptospirosis causes very specific organ damage to the liver, kidneys, central nervous system (CNS) and heart; predictors of survival that are applicable to these diseases are hence likely to be different in the case of leptospirosis infection. We sought to develop a classification system based on the PIRO concept, which is specifically applicable and clinically relevant in predicting the severity of leptospirosis.

The PIRO staging system for severe sepsis not only classifies prognostic indicators but also provides a scoring system to quantify the probable outcome (each category is assigned a staging number, i.e., P1, P2, R1, etc., with higher numbers predicting increased mortality). This review classifies the prognostic indicators for severe leptospirosis according to the PIRO model but stops short of developing a scoring system. Available data were inadequate, and non-comparable due to differences in study methodology, to develop a valid scoring system. It is our opinion that such quantification is best handled by a well-designed, dedicated, prospective study rather than by a literature review. Still, this work serves as a concept paper to show the possibility and relevance of such a scoring system.


   Material and Methods Top


A PUBMED search was performed for all articles with the key word "leptospirosis" in any field. The search was restricted to articles published in English within the last 20 years (1989-May 2009) as they would contain more recent data. There were 1898 abstracts in the original search with these restrictions. The software, Endnote X1, was used to filter articles. Bibliographies of cited literature were also searched. All abstracts were read through independently by the three authors and relevant papers were identified for review of the full papers. Related papers were also included. We reviewed 163 selected papers.

These sources were screened for a well-described methodology, accurate statistical analysis and an adequate sample size where relevant. Identification of prognostic indicators was performed by three reviewers independently blinded to each other. Later, they were classified into each component of the PIRO model by consensus. While such a classification was possible, the development of a scoring system based on it was not possible for the reasons mentioned above (non-comparability of data). Data sources included reviews published in core clinical journals, cohort studies, interventional studies, case control studies, cross-sectional analysis and epidemiological data. Suitable data were available in 45 papers from the initially selected 163. A summary of the cited literature is shown in [Table 1],[Table 2],[Table 3],[Table 4].


   Comprehensive Discussion of Mortality Predictors with Concurrent Classification into the PIRO Model Top


The following four sections are titled according to the four components of the PIRO model. Mortality predictors for leptospirosis reported by various authors are discussed under each subtopic.

Predisposition

Three mortality indicators were reported in the literature that can be classified under predisposition: age, alcohol dependence and male sex. A summary of the studies in this regard is given in [Table 1].

Five studies have reported age as an indicator. Cetin et al.[6] published a retrospective analysis of 16 patients with leptospirosis and renal failure. Survivors had a mean age of 34 years, while the deceased had a mean age of 60.7 years (Mann Whitney U-test, 0.008). Chawla et al.[7] described age over 50 years as a mortality indicator in a sample of 60 critically ill patients in an intensive care unit (ICU) setting. Ko et al.0,[8] in a prospective study of 396 clinically defined cases, suggest that age over 36 years is significantly associated with death (OR, 4.25). Lopez et al.,[9] in a retrospective study of 840 leptospirosis patients, concluded that the odds of death adjusted for gender, jaundice, duration of symptoms, serum urea and serum creatinine were almost four times higher for the adult group than for the pediatric group (OR, 3.94). Among adults also, increasing age was significantly and independently associated with death. Spichler et al.[4] showed that age over 40 is a risk factor for death (retrospective case control study with 370 patients).

Only Chawla et al.[7] reported male sex as an independent predictor of death. Data from two other studies [10],[11] failed to find such an association.

Chronic alcoholism was reported to be significantly associated with death in two studies. [7],[12] Martinez et al.0,[13] in a retrospective analysis of 17 patients with pulmonary involvement, found cigarette smoking to be significantly associated with disease severity but not mortality.

On analyzing the available evidence, the strongest predictor of mortality under "predisposition" is increasing age. The evidence for poor outcome among males is limited (two large retrospective studies failed to show such an association). [10],[11] Jansen et al.[10] suggested that male sex is significantly associated with severity of disease but does not predict mortality. Two large prospective studies showed that chronic alcoholism is an important predictor of mortality, although most other studies do not mention this in the published literature. Whether this increased risk is due to leptospirosis per se or due to hepatic dysfunction on a background of alcoholic liver disease is not clear.

While there are many predisposing factors for contracting leptospirosis (walking barefoot, contact with farm animals and rodents, wet soil around the house, activities in forests, rainfall), none of these have been reported to predict outcome after acquiring the infection. [14],[15],[16],[17],[18] Male sex and age have been cited as predictors of infection as well as mortality.

Infection

The classifiable material under this topic is minimal [Table 2]. Trucculo et al.[19] measured the number of leptospires (by polymerase chain reaction) recovered from the blood of patients with leptospirosis, and showed that >10 4 leptospires/ml were associated with death. These findings were confirmed by Segura et al.[20] in an independent, prospective population-based study.

Response

We encountered difficulty in differentiating mortality indicators under response and organ dysfunction categories as such a division seemed arbitrary. Therefore, the items categorized under the response section are restricted to components of severe inflammatory response syndrome (SIRS) and a few other indicators such as abdominal pain and muscle tenderness [Table 3].

Pertuiset et al.[12] report tachypnoea (respiratory rate over 24/min) as a predictor of mortality while Pappachan et al.[21] identified tachycardia as a risk indicator (OR, 4.1). Hypotension was associated with mortality in three studies. [22],[23],[24] Leukocytosis (total count above 12,000) has also been reported as a mortality predictor by some. [25]

Abdominal pain is also reported as a mortality indicator by Pertuiset et al.,[12] although other studies do not show supportive evidence. Pappachan et al.[21] describe generalized muscle tenderness as a mortality predictor (P = 0.03).

Other indicators classifiable under this section include high tumor necrosis factor alpha (TNF α) levels (Tajiki et al., P = 0.02), platelet count <70,000 (Spichler et al., OR: 2.6) and high cerebrospinal fluid protein levels in patients with neuroleptospirosis (Mathew et al., P < 0.001). [4],[26],[27],[28]

Of all these indicators, only hypotension was confirmed as a predictor of mortality in three independent studies with an adequate sample size. [22],[2]3,[24] Other associations such as tachycardia, leucocytosis and TNF α levels have not been confirmed by independent studies. However, Niwatthayakul et al.[29] observed that in a series of 34 patients with renal failure, TNF α levels were high in severely ill patients. This is an area for further research. It is notable that markers of inflammation such as C-reactive protein and erythrocyte sedimentation rate have not been adequately assessed with regard to mortality.

Organ dysfunction


Three organ systems are commonly cited as involved in severe leptospirosis: the lungs, the kidneys and the CNS [Table 4].

Although relatively uncommon, pulmonary involvement has been repeatedly and consistently incriminated as a mortality predictor in more than 10 studies. Pertuiset et al.[12] and Dupont et al.[25] reported that radiographical evidence of pulmonary involvement is a predictor of mortality. Similarly, Shenoy et al.,[30] in a prospective study, reported that mortality correlates positively with the number of lung quadrants involved on the chest radiograph. Abnormal chest auscultation, [22] dyspnoea [23] and the presence of pulmonary rales [25] are also associated with increased mortality. Several other studies showing an association between pulmonary involvement and mortality are summarized in [Table 4].[4],[11],[31],[32],[33]

While many manifestations of lung involvement are mild, pulmonary hemorrhage is associated with a high mortality. Patients also die from acute lung injury (ALI), acute respiratory distress syndrome and combined MODS. Respiratory symptoms appear on the 4 th -6 th days of disease and can progress rapidly to death within 72 h. Mortality rates from different studies vary between 30% and 60%. Different aspects of lung involvement such as clinical signs, radiographical evidence and ALI are all predictors of mortality. [34],[35]

Acute renal failure (ARF) and its manifestations are also reported as mortality indicators. Oliguria and anuria are cited as independent predictors of mortality in six studies. [4],[6],[22],[23],[25],[36] Elevated serum potassium is reported as an indicator in seven studies. [6],[21],[23],[24],[37],[38],[39] Serum creatinine level above 3 mg/dl is also shown to correlate with death. [4],[24] Acidosis, which may indicate pulmonary or renal involvement, is reported as a predictor of death in two studies. [7],[40] A statistically significant association between established renal failure and death is reported in another two studies. [8],[41]

Bacterial infection, insults from the inflammatory process, and hemodynamic disturbances are thought to contribute to renal failure in leptospirosis. The basic pathology is an interstitial nephritis with tubular necrosis resulting in ARF. Manifestations of renal involvement vary from laboratory evidence (changes in urinary sediment, evidence of tubular dysfunction) to clinically defined ARF with hyperkalaemia and elevated creatinine. [42] It is estimated that 44-67% of the patients can have renal failure in leptospirosis. [6] The mortality rates published from such involvement vary according to the locality studied (26% in Sri Lanka, 36% in Barbados). [43],[44]

Central nervous system involvement is another predictor of severe disease and death. Covic et al.[45] published a retrospective study on 51 patients with severe leptospirosis. Altered level of consciousness was seen in all patients who died, but this was only 33% in the patients who survived (P < 0.05). Esen et al.[39] also reported a significantly high rate of altered mental status (P = 0.01) in deceased patients compared to survivors (retrospective analysis of 72 patients). According to Ko et al.,[8] who studied 326 patients prospectively, altered mental status was the strongest predictor of death (OR, 9.12). Mathew et al.,[27] reporting on a retrospective and a prospective study of 31 patients with neuroleptospirosis, suggested that deep altered sensorium at presentation correlated with mortality ( P < 0.037). Meningism and disorientation (OR, 5 and 10.6, respectively) are also reported as mortality indicators by Pappachan et al.[21]

Three studies have independently associated altered mental status with death. However, many factors can cause altered mental status in severe leptospirosis, and thus this clinical feature is lacking in specificity. These studies also do not specify the criteria used to assess altered mental status and hence it is difficult to assess the uniformity of the findings.

Cardiac involvement in leptospirosis is underestimated. Describing the findings of 44 autopsies with a presumptive cause of death with leptospirosis-related complications, Charkurkar et  al.[46] reported interstitial myocarditis in 100% of the cases, with involvement of the epicardium or endocardium (39%), valves (36%), coronary arteries (51%) and aorta (56%). However, clinical manifestations of cardiac involvement were limited. Dupont et al.,[25] in his retrospective study, reported several ECG abnormalities, including, sinus tachycardia and bradycardia, repolarization abnormalities, conduction abnormalities, atrial/ventricular extrasystoles and atrial fibrillation. Only repolarization abnormalities were shown to be a predictor of mortality.

Evidence for hepatic dysfunction is prominent during the clinical course of leptospirosis. However, many of these are not reported as predictors of mortality. Pappachan et al.[21] reported that serum bilirubin above 15 mg/dl is an indicator of death (OR, 5.4) while Cetin et al.[6] reported a much higher limit of 36 mg/dl. Similarly, Chang et al. reported that a high Aspartate transaminase (AST)/alanine transaminase (ALT) ratio in late disease is associated with death. [28] Bleeding diathesis was reported as a mortality indicator by Covic et al.[45]

MODS, which is the involvement of more than one organ system, has been shown to be associated with death in four studies [Table 4]. [7],[30],[40],[45]


   Problems in Classification and Potential for Further Development Top


There were a few other predictors of mortality that could not be classified under the PIRO model. These were mainly treatment related. Andrade et al.,[47] in a two-sample cohort study, have shown that prompt and daily dialysis had a survival advantage over alternate-day dialysis for patients in ARF (P = 0.01). In their study involving 35 critically ill patients with ARF, Vieira et al.[40] stated that length of stay in ICU is positively associated with mortality. A review in Thailand has shown that blood exchange therapies (hemodialysis, hemofiltration) were associated with lower mortality (0 vs. 10%), shorter recovery time (8 vs. 16 days) and faster reduction in serum levels of bilirubin, urea and creatinine when compared to peritoneal dialysis. [48]

There is a place for further research to determine the role of gender, infecting serovars, clinical signs, inflammatory markers, cytokines, biochemical parameters and markers of hepatic dysfunction as prognostic indicators. It is interesting to note that several recent studies in India have shown that clinical manifestations like pancreatitis and syndrome of inappropriate secretion of anti-diuretic hormone were more common than previously thought. In one study, the majority of patients with these presentations were anicteric. There may be many other predictors of mortality yet unidentified in relation to these presentations. [49]


   Limitations Top


Only articles published in English were included in the review. Therefore, it is possible that certain important papers were missed. Similarly, relevant information published beyond the time limits of our search have not been taken into account. Such gaps in data may affect the validity and generalizability of the conclusions.


   Conclusions Top


This review was synthesized as a concept paper to direct further research into mortality indicators of leptospirosis.

It attempts to

  1. summarize and discuss evidence on predictors of mortality in severe letospirosis
  2. develop a classification system for such factors based on the PIRO concept used for staging of severe sepsis


On analyzing the evidence on mortality indicators, some predictors (age, renal/pulmonary involvement and multiple organ dysfunction) have been repeatedly and independently confirmed by different authors. Still, some other associations such as the impact of inflammatory markers and leukocytosis have not been assessed in detail. Many identified risk factors could be categorized into the four domains of the PIRO concept. However, treatment-related factors could not be incorporated into the existing model. In this regard, we propose to add a fifth domain of treatment (T) when modifying the PIRO concept for leptospirosis.

While we managed to classify the mortality indicators, a scoring system to quantify the relative risk could not be developed due to differences of the methodologies and non-comparability of data. Such a scoring/staging system would be more scientifically valid if developed by a prospective study specially designed for such a purpose. It is hoped that our work will be a starting point to the development of a staging system to predict the severity of leptospirosis.[50]

 
   References Top

1.Wikipedia Leptospira. Available from: http://www.en.wikipedia.org/wiki/Leptospira [last accessed on 2009 Nov 18].  Back to cited text no. 1      
2.Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: An emerging global public health problem. J Biosci 2008;33:557-69.  Back to cited text no. 2      
3.The leptospirosis information centre. Case statistics and incidence for human leptospirosis. Available from: http://www.leptospirosis.org/topic.php?t=44 [last accessed on 2009].  Back to cited text no. 3      
4.Spichler AS, Vilaca PJ, Athanazio DA, Albuquerque JO, Buzzar M, Castro B, et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg 2008;79:911-4.  Back to cited text no. 4      
5.Rubulotta F, Marshall JC, Ramsay G, Nelson D, Levy M, Williams M. Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med 2009;37:1329-35.  Back to cited text no. 5      
6.Cetin BD, Harmankaya O, Hasman H, Gunduz A, Oktar M, Seber E. Acute renal failure: a common manifestation of leptospirosis. Ren Fail 2004;26:655-61.  Back to cited text no. 6      
7.Chawla V, Trivedi TH, Yeolekar ME. Epidemic of leptospirosis: An ICU experience. J Assoc Physicians India 2004;52:619-22.  Back to cited text no. 7      
8.Ko AI, Galvγo Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW. Urban epidemic of severe leptospirosis in Brazil: Salvador Leptospirosis Study Group. Lancet 1999;354:820-5.  Back to cited text no. 8      
9.Lopes AA, Costa E, Costa YA, Sacramento E, de Oliveira AR Jr, Lopes MB, et al. Comparative study of the in-hospital case-fatality rate of leptospirosis between pediatric and adult patients of different age groups. Rev Inst Med Trop Sao Paulo 2004;46:19-24.  Back to cited text no. 9      
10.Jansen A, Stark K, Schneider T, Schoneberg I. Sex differences in clinical leptospirosis in Germany 1997-2005. Clin Infect Dis 2007;44:e69-72.  Back to cited text no. 10      
11.Papa A, Theoharidou D, Antoniadis A. Pulmonary involvement and leptospirosis, Greece. Emerg Infect Dis 2009;15:834-5.  Back to cited text no. 11      
12.Pertuiset E, Fen Chong M, Duval G, Genin R. [Clinical aspects and prognostic factors of icterohemorrhagic leptospirosis in adults: Apropos of 249 cases in La Reunion]. Rev Med Interne 1988;9:487-93.  Back to cited text no. 12      
13.Martinez Garcia MA, de Diego Damia A, Menendez Villanueva R, Lopez Hontagas JL. Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 2000;19:471-4.  Back to cited text no. 13      
14.Barcellos C, Sabroza PC. Socio-environmental determinants of the leptospirosis outbreak of 1996 in western Rio de Janeiro: A geographical approach. Int J Environ Health Res 2000;10:301-13.  Back to cited text no. 14      
15.Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: A population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol 1999;28:583-90.  Back to cited text no. 15      
16.Dias JP, Teixeira MG, Costa MC, Mendes CM, Guimaraes P, Reis MG, et al. Factors associated with Leptospira sp infection in a large urban center in northeastern Brazil. Rev Soc Bras Med Trop 2007;40:499-504.  Back to cited text no. 16      
17.Conti E, Lazzarini L, Reatto P, Tositti G, de Lalla F. Human leptospirosis in the Vicenza area (Italy) from 1990 to 2003: An epidemiological and clinical study. Infez Med 2005;13:235-40.  Back to cited text no. 17      
18.Barcellos C, Sabroza PC. The place behind the case: Leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cad Saude Publica 2001;17:59-67.  Back to cited text no. 18      
19.Truccolo J, Serais O, Merien F, Perolat P. Following the course of human leptospirosis: Evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett 2001;204:317-21.  Back to cited text no. 19      
20.Segura ER, Ganoza CA, Campos K, Ricaldi JN, Torres S, Silva H, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 2005;40:343-51.  Back to cited text no. 20      
21.Pappachan MJ, Mathew S, Aravindan KP, Khader A, Bharghavan PV, Kareem MM, et al. Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India 2004;17:240-2.  Back to cited text no. 21      
22.Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect 2006;12:299-300.  Back to cited text no. 22      
23.Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: A prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 2002;6:52-9.  Back to cited text no. 23      
24.Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, et al. Acute lung injury in leptospirosis: Clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999;29:1561-3.  Back to cited text no. 24      
25.Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Daijardin JB. Leptospirosis: Prognostic factors associated with mortality. Clin Infect Dis 1997;25:720-4.  Back to cited text no. 25      
26.Tajiki H, Salomao R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 1996;23:1177-8.  Back to cited text no. 26      
27.Mathew T, Satishchandra P, Mahadevan A, Nagarathna S, Yasha TC, Chandramukhi A, et al. Neuroleptospirosis - revisited: Experience from a tertiary care neurological centre from south India. Indian J Med Res 2006;124:155-62.  Back to cited text no. 27      
28.Chang ML, Yang CW, Chen JC, Ho YP, Pan MJ, Lin CH, et al. Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis. World J Gastroenterol 2005;11:5553-6.  Back to cited text no. 28      
29.Niwattayakul K, Homvijitkul J, Niwattayakul S, Khow O, Sitprija V. Hypotension, renal failure, and pulmonary complications in leptospirosis. Ren Fail 2002;24:297-305.  Back to cited text no. 29      
30.Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: An excellent response to bolus methylprednisolone. Postgrad Med J 2006;82:602-6.  Back to cited text no. 30      
31.Budiono E, Sumardi BS, Hisyam RB, Hartopo AB. Pulmonary involvement predicts mortality in severe leptospirosis patients. Acta Med Indones 2009;41:11-4.  Back to cited text no. 31      
32.Paganin F, Bourdin A, Dalban C, Courtin JP, Poubeau P, Borgherini G, et al. Leptospirosis in Reunion Island (Indian Ocean): Analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med 2007;33:1959-66.  Back to cited text no. 32      
33.Bharadwaj R, Bal AM, Joshi SA, Kagal A, Pol SS, Garad G, et al. An urban outbreak of leptospirosis in Mumbai, India. Jpn J Infect Dis 2002;55:194-6.  Back to cited text no. 33      
34.Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis 2007;11:142-8.  Back to cited text no. 34      
35.Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CR. Leptospiral pneumonias. Curr Opin Pulm Med 2007;13:230-5.  Back to cited text no. 35      
36.Daher EF, Silva GB Jr, Karbage NN, Carvalho PC Jr, Kataoka RS, Silva EC, et al. Predictors of oliguric acute kidney injury in leptospirosis: a retrospective study on 196 consecutive patients. Nephron Clin Pract 2009;112:c25-30.  Back to cited text no. 36      
37.Cerqueira, TB, Athanazio DA, Spichler AS, Seguro AC. Renal involvement in leptospirosis-new insights into pathophysiology and treatment. Braz J Infect Dis 2008;12:248-52.  Back to cited text no. 37      
38.Lopes AA, Costa E, Costa YA, Bina JC, Sacramento E. The association between serum potassium at hospital admission and the case-fatality rate of leptospirosis in men. Rev Inst Med Trop Sao Paulo 2001;43:217-20.  Back to cited text no. 38      
39.Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly 2004;134:347-52.  Back to cited text no. 39      
40.Vieira SR, Brauner JS. Leptospirosis as a cause of acute respiratory failure: clinical features and outcome in 35 critical care patients. Braz J Infect Dis 2002;6:135-9.  Back to cited text no. 40      
41.Bhardwaj P, Kosambiya JK, Desai VK. A case control study to explore the risk factors for acquisition of leptospirosis in Surat city, after flood. Indian J Med Sci 2008;62:431-8.  Back to cited text no. 41  [PUBMED]  Medknow Journal  
42.Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med 2005;51:184-8.  Back to cited text no. 42  [PUBMED]  Medknow Journal  
43.Nicholson GD, Edwards CN, Hassell TA, Everard CO, Callender J. Urinary diagnostic indices in the management of leptospirosis: Selection of patients for dialysis therapy. West Indian Med J 1989;38:33-8.  Back to cited text no. 43      
44.Ramachandran S, Rajapakse CN, Perera MV, Yoganathan M. Patterns of acute renal failure in leptospirosis. J Trop Med Hyg 1976;79:158-60.  Back to cited text no. 44      
45.Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Seica A, Covic M. A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant 2003;18:1128-34.  Back to cited text no. 45      
46.Chakurkar G, Vaideeswar P, Pandit SP, Divate SA. Cardiovascular lesions in leptospirosis: An autopsy study. J Infect 2008;56:197-203.  Back to cited text no. 46      
47.Andrade L, Cleto S, Seguro AC. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: Impact on mortality. Clin J Am Soc Nephrol 2007;2:739-44.  Back to cited text no. 47      
48.Wiwanitkit V. Comparison between blood exchange and classical therapy for acute renal failure in Weil′s disease: appraisal on Thai reports. Nephrology (Carlton) 2006;11:481.  Back to cited text no. 48      
49.Izurieta R, Galwankar S, Clem A. Leptospirosis: The mysterious ′mimic′. J Emerg Trauma Shock 2008;1:21-33.  Back to cited text no. 49  [PUBMED]  Medknow Journal  
50.Clerke AM, Leuva AC, Joshi C, Trivedi SV. Clinical profile of leptospirosis in South gujarat. J Postgrad Med 2002;48:117-8.  Back to cited text no. 50  [PUBMED]  Medknow Journal  

Top
Correspondence Address:
Senaka Rajapakse
Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo
Sri Lanka
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2700.66519

Rights and Permissions



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]

This article has been cited by
1 Leptospirosis: diagnóstico diferencial de fiebre en urgencias
S. López-Cuenca,J.A. Álvarez-Fernández
SEMERGEN - Medicina de Familia. 2014;
[Pubmed] | [DOI]
2 High dose corticosteroids in severe leptospirosis: a systematic review
C. Rodrigo,N. Lakshitha de Silva,R. Goonaratne,K. Samarasekara,I. Wijesinghe,B. Parththipan,S. Rajapakse
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014;
[Pubmed] | [DOI]
3 Profile of acute kidney injury in pediatric leptospirosis
Francisco E. Anacleto,Almira B. Collado,Angeli M. Wyson
Renal Failure. 2014; : 1
[Pubmed] | [DOI]
4 Low serum total nitrite and nitrate levels in severe leptospirosis
Kalugalage, T. and Rodrigo, C. and Vithanage, T. and Somaratne, P. and De Silva, H.J. and Handunnetti, S. and Rajapakse, S.
BMC Infectious Diseases. 2013; 13(1)
[Pubmed]
5 Leptospirosis in Franche-Comté (FRANCE): Clinical, biological, and therapeutic data
J.M. Estavoyer,C. Chirouze,J.F. Faucher,N. Floret,G. Couetdic,J. Leroy,B. Hoen
Médecine et Maladies Infectieuses. 2013; 43(9): 379
[Pubmed] | [DOI]
6 Low serum total nitrite and nitrate levels in severe leptospirosis
Thilini Kalugalage,Chaturaka Rodrigo,Thamal Vithanage,Pranitha Somaratne,H Janaka De Silva,Shiroma Handunnetti,Senaka Rajapakse
BMC Infectious Diseases. 2013; 13(1): 206
[Pubmed] | [DOI]
7 Cardiac involvement in leptospirosis
Mitrakrishnan Rayno Navinan,Senaka Rajapakse
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2012; 106(9): 515
[Pubmed] | [DOI]
8 Serum nitrite levels in Sri Lankan patients with leptospirosis
Rohini I Gunaratna,Shiroma M Handunnetti,MRC Bulathsinghalage,Pranitha Somaratne,Ananda Jayanaga,HJ de Silva,Senaka Rajapakse
Asian Pacific Journal of Tropical Medicine. 2012; 5(1): 75
[Pubmed] | [DOI]
9 Cardiac involvement in leptospirosis
Navinan, M.R. and Rajapakse, S.
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2012; 106(9): 515-520
[Pubmed]
10 Leptospirosis presenting as acute encephalitis syndrome (AES) in Assam, India
Khan, S.A. and Dutta, P. and Borah, J. and Chowdhury, P. and Topno, R. and Baishya, M. and Mahanta, J.
Asian Pacific Journal of Tropical Disease. 2012; 2(2): 151-153
[Pubmed]
11 A ten-year follow-up of human leptospirosis in uruguay: An unresolved health problem [Diez años de seguimiento de la leptospirosis humana en Uruguay: Un problema de salud no resuelto]
Schelotto, F. and Hernández, E. and González, S. and del Monte, A. and Ifran, S. and Flores, K. and Pardo, L. and Parada, D. and Filippini, M. and Balseiro, V. and Geymonat, J.P. and Varela, G.
Revista do Instituto de Medicina Tropical de Sao Paulo. 2012; 54(2): 69-75
[Pubmed]
12 Leptospirosis presenting as acute encephalitis syndrome (AES) in Assam, India
SA Khan,P Dutta,J Borah,P Chowdhury,R Topno,M Baishya,J Mahanta
Asian Pacific Journal of Tropical Disease. 2012; 2(2): 151
[Pubmed] | [DOI]



 

Top
 
  Search
 
  
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Background
    Material and Methods
    Problems in Clas...
    Limitations
    Conclusions
    Predictors of Mo...
    Comprehensive Di...
    References
    Article Tables

 Article Access Statistics
    Viewed5297    
    Printed223    
    Emailed0    
    PDF Downloaded141    
    Comments [Add]    
    Cited by others 12    

Recommend this journal